Since its introduction in 1980 (1), percutaneous endoscopic gastrostomy (PEG) has been used extensively to provide long-term enteral nutrition in a variety of clinical conditions in childhood, especially in children with an intact gastrointestinal tract who cannot eat because of abnormalities of the swallowing mechanism.
This procedure is safer and easier to administer, with shorter procedure time, and is less expensive than is surgical gastrostomy(2,3). However, complications have been reported to include gastric bleeding, gastric tear, colonic perforation, tube migration, aspiration related to gastroesophageal reflux (GER), stomal leakage, wound infection, and peritonitis. Technical improvements by numerous practitioners have helped to reduce some complications associated with PEG placement(4). However, abnormal GER remains a serious problem(1). It is difficult to predict which patients will subsequently experience abnormal reflux that cannot be controlled by medical therapy, but it has been suggested that fundoplication and open gastrostomy rather than PEG be performed in all neurologically impaired children(5). This approach has been challenged(6). It appears that the increased risk of an antireflux procedure in these patients (7) should be weighed against possible complications resulting from GER.
The current study was undertaken to assess indications, the rate of complications, the success of nutritional rehabilitation, and the incidence of pathologic GER after PEG in a large pediatric population. In addition, we evaluated whether 24-hour pH monitoring of the esophagus before PEG was useful in predicting later complications related to GER.
PATIENTS AND METHODS
The charts of all patients seen by Louisiana State University Pediatric Associates at Children's Hospital of New Orleans and who underwent PEG from November 1, 1990, to May 31, 1995, were reviewed. We recorded age and sex of the patients, indications for PEG, diagnoses, procedure duration, type of anesthesia or sedation, and acute procedure-related complications. Patients were observed for 1 to 4 years and data regarding weight gain, late complications related to the gastrostomy, and incidences of GER were collected. Data from pH probe studies before placement of the PEG tube, medical therapy for reflux, and the number of surgical antireflux procedures(Nissen fundoplication) after PEG were recorded.
Percutaneous endoscopic gastrostomy was performed jointly by a pediatric surgeon and a pediatric gastroenterologist. Using a modification of the technique described by Gauderer et al. (1), in most cases BARD PEG kits (15 or 20 F C. R. Bard Inc., Tweksbury, MA, U.S.A.) were used. The procedure was performed in an endoscopy suite, in a recovery room, or in an operating room, with close monitoring of heart rate, respiratory rate, blood pressure, electrocardiogram, and oxygen saturation (pulse oximeter). Antibiotic prophylaxis (usually cefazolin) was given to all patients before surgery and in the immediate postoperative period.
Enteral feedings were begun 12 to 24 hours after the procedure. Twenty-four-hour pH probe monitoring was performed 1 to 90 days (mean 38 days) before PEG, using an antimony electrode placed at T7-T8 (verified by chest radiograph) and connected to a pH meter (Digitrapper Mark III Meditronic Synectics, Shoreview, MN, U.S.A.). For infants under 1 year old, results were considered abnormal if the reflux index (percentage of time pH is below 4) was more than 10%, if the number of reflux episodes longer than 5 minutes was more than 8, or if the longest episode lasted more than 40 minutes(8). For patients more than 1 year old, pH probe results were considered abnormal if the reflux index was more than 6%, if the number of episodes longer than 5 minutes was more than 1, or if the longest episode lasted more than 11 minutes (9). All antireflux and antiacid medications were stopped 48 hours before the study. During pH monitoring, regular oral feedings or bolus feedings were given by nasogastric tube, with at least a 2-hour postprandial period.
Weight measurements were recorded and standardized, usingz- scores (10). A repeated measurements analysis of variance (ANOVA) was used to evaluate differences in z-scores before and after PEG.
RESULTS
Eighty-five patients (49 males and 36 females) underwent PEG during the study period. The age of the patients ranged from one month to 22 years (mean, 7 years). The most common indication for PEG was inability to ingest sufficient amounts of food orally because of the absence of oropharyngeal coordination often associated with aspiration (88%). The remaining patients required PEG for provision of supplemental calories (n = 7), for special diets (n = 2), or for gastric drainage (n = 1). Seventy-nine patients (93%) were neurologically impaired(Table 1). The other patients had gastrointestinal or cardiorespiratory disorders. In 70 patients, PEG was performed, using intravenous sedation (usually 1-2 mg/kg meperidine with 1-10 mg midazolam). Fifteen patients received general anesthesia. The mean procedure time was 15 minutes (range, 10-35 minutes). There were no deaths related to the procedure, and no acute procedure-related complications were encountered. There were two major complications related to the feeding tube: In 1 patient, the feeding tube was prematurely removed by traction 2 weeks after PEG, resulting in separation of the abdominal wall and stomach. Immediate surgical repair was required. In another patient, the external bolster became embedded beneath the skin, causing severe local infection. At the same time, the internal crosshead had migrated into the gastric submucosa, requiring removal of the tube and replacement by a Foley catheter. Minor complications, including transient superficial wound infection (n = 6), stomal leakage of gastric content (n = 3), erythema around the gastrostomy site (n = 4), and dislodging of the tube into the duodenum (n = 1) occurred in 14 patients (16.5%). The gastrostomy tube was accidentally pulled out in 1 patient.
Eighty-one of the 85 patients had a weight below the 5th percentile weight-for-age (U. S. National Center for Health Statistics). As shown inFigure 1, the z-score for weight increased significantly after 6 and 12 months of nutritional support. Thez- score improved in 81 patients (95%), remained unchanged in 2, and decreased in 2. One of the latter 2 patients had multiple organ failure. Hisz- score improved during the second year of follow-up. The other patient was neglected at home. His z-score improved during the third year of follow-up after he was placed in foster care.
A 24-hour esophageal pH probe study was performed in 46 patients before PEG. Most of these patients (94%) underwent PEG after January 1993, when pH monitoring had become a routine preoperative procedure, regardless of symptoms. The results were normal in 22 patients (group 1) and abnormal in 24 patients (group 2). Of the patients in group 1, 5 required medical treatment for symptoms of GER that developed after PEG. These symptoms included mild regurgitation, wheezing, occasional hematemesis, and irritability. However, only 1 of those 22 patients (5%) required a surgical antireflux procedure(Nissen fundoplication) 22 months later. In contrast, 19 of the 24 patients in group 2 required continuing medical therapy for symptomatic GER. A surgical anti-reflux procedure was performed in 7 (29%) of them, 4 to 22 months after PEG. All 7 were neurologically impaired. The indication for fundoplication was frequent, excessive regurgitation of formula, leading to aspiration pneumonia or to severe electrolyte imbalance. The difference in the number of fundoplications required between the 2 groups of patients (normal vs. abnormal pH probe results before PEG) was statistically significant (p < 0.05; Fisher's exact test).
To assess the impact of nutritional status on the severity of GER and the need for fundoplication, we evaluated the z-scores of the eight patients undergoing an antireflux procedure separately. All eight patients had improved their z-scores for weight from -2.5 ± 0.5 to -0.7± 0.5 (mean ± SEM) at the time of surgery, which was performed an average of 11 months after PEG. This improved z-score was not different from that observed 12 months after PEG in patients not requiring Nissen fundoplication (-0.6 ± 0.2).
DISCUSSION
Our results suggest that, in general, PEG is a safe and effective technique for providing enteral feedings to children who need long-term nutritional support. There was no procedure-related mortality. The incidence of feeding tube-related major complications (defined as those requiring surgical intervention) was only 2% and that of minor complications 16%. These numbers compare favorably with other reports in the pediatric literature(4, 11-13). Percutaneous endoscopic gastrostomy may have fewer complications than Stamm gastrostomy because general anesthesia is usually not required, the procedure time is short, and surgery is minimally invasive (14,15). The two major complications that occurred in our series could have been avoided if, in one patient, the feeding tube had not been removed prematurely and, in the other, local infection had been treated early and the tube had been regularly checked to ascertain that the external bolster was sufficiently loose.
The most common minor complication in our series was superficial wound infection after PEG (7%). Davidson et al. (12) reported a somewhat higher rate of wound infection (13%). The difference may be that only 70% of their patients received perioperative antibiotic prophylaxis, opposed to 100% of our patients. Indeed, they noted that in their patients, wound infection was significantly more likely to develop if antibiotic prophylaxis had not been given. We agree with their conclusion that antibiotic prophylaxis should be used routinely.
To evaluate the success of nutritional therapy, we expressed the weight gain during a 1-year follow-up period as z-score, which normalizes the data to a reference population (10). Our findings support results from previous studies that demonstrate clear nutritional benefit from PEG in children (13,16).
Abnormal GER was a common problem in our patients, perhaps because 93% were neurologically impaired. The high incidence of abnormal GER in neurologically handicapped children has been well documented (17). Whether PEG aggravates GER is controversial. It has been suggested that symptomatic GER occurs frequently after PEG or Stamm gastrostomy, but that severe GER requiring fundoplication is less common after PEG than it is after Stamm gastrostomy (15). In the largest series of PEG in children, long-term follow-up on 194 patients revealed an incidence of subsequent surgical intervention for GER of 13% (18). All patients who required surgery for GER were neurologically impaired. This incidence is comparable with that reported in other studies(12,16) and with our experience.
One way to evaluate the impact of PEG on GER might be to compare findings in 24-hour esophageal pH monitoring before and after PEG. However, such studies are hampered because pH monitoring can only detect acid GER, and results are difficult to interpret because of differences in feeding regimens, the use of antireflux medications, differences in the use of age related reference data, and too short a follow-up period(19,20). We therefore decided to relate data obtained in pre-PEG esophageal pH monitoring to clinical follow-up data of at least 1 year. We tried to circumvent some of the problems inherent in pH monitoring by assuring that, during the test, our patients had an at least 2-hour postpradial period, that antireflux and antacid medication were discontinued, and that abnormal results were clearly defined, using published age-related reference data.
The most reliable indication that GER has become a serious clinical problem after PEG is the necessity for a surgical antireflux procedure. This procedure is performed if GER cannot be controlled by medical treatment and appropriate adjustments of the feeding regimen. In our results, 29% of patients who had abnormal findings in pH monitoring before PEG had GER symptoms of such severity that an antireflux procedure was performed. Little information about the correlation between esophageal pH monitoring before PEG and the requirement for fundoplication after PEG is available in the pediatric literature. Grunow et al. observed 10 patients with normal pH readings before PEG (19). Although 6 of them had abnormal pH probe results after PEG, only 1 required fundoplication. More recently, Davidson et al. reported esophageal pH monitoring on 32 patients before PEG, of whom 21 had normal and 11 had abnormal results (12). Seven of their patients required later fundoplication. Unfortunately, a correlation between pre-PEG pH monitoring results and the later need for fundoplication is not given in their report. Jolley et al. reported 32 neurologically impaired children (5). Nine of them had normal esophageal pH readings and underwent PEG. Three of these 9 patients later required fundoplication. Almost all their patients with an abnormal pH reading received an antireflux procedure at the same time of placement of a feeding gastrostomy. These investigators concluded that a protective fundoplication should be performed in all neurologically impaired children. Our data do not support such a conclusion, because we had 20 patients with normal pH readings before PEG, but only one had GER to such a degree that fundoplication was required. Our data also do not support the notion that improved nutritional status after PEG has a positive impact on GER (21). All our patients who required an antireflux procedure had improved nutritional status comparable with that of the remainder of the patients when surgery became inevitable.
We conclude that a normal esophageal pH reading before PEG, performed and interpreted as described above, may be predictive of a favorable outcome in GER. Even though some of these patients may have reflux symptoms after PEG, a need for a later surgical antireflux procedure would be unlikely. This is in contrast to patients with abnormal pH readings before PEG, of whom a relatively large percentage (29%) may require such a procedure later. Whether these patients should undergo a protective antireflux procedure at the time of gastrostomy placement is debatable. The approach to these patients should probably be according to individual needs.
REFERENCES
1. Gauderer MWL, Ponsky JL, Izant RI Jr. Gastrostomy without laparotomy-a percutaneous endoscopic technique. J Pediatr Surg 1980;15:872-5.
2. Russell TR, Brotman M, Norris F. Percutaneous gastrosotmy: A new simplified and cost-effective technique. Am J Surg 1984;148:132-5.
3. Sangster W, Cuddington GD, Bachulis BL. Percutaneous endoscopic gastrostomy. Am J Surg 1988;155:677-9.
4. Beasley SW, Catto-Smith AG, Davidson PM. How to avoid complications during percutaneous endoscopic gastrostomy. J Pediatr Surg 1995;30:671-3.
5. Jolly SG, Smith I, Tunell WP. Protective antireflux operation with feeding gastrostomy. Experience with children. Ann Surg 1985;201:736-9.
6. Langer JC, Wesson DE, Ein SH, et al. Feeding gastrostomy in neurologically impaired children is an antireflux procedure necessary?J Pediatr Gastroenterol Nutr 1988;7:837-41.
7. Dedinsky GK, Vane DW, Black T, Turner MK, West KW, Grosfeld JL. Complications and reoperation after Nissen fundoplication in childhood. Am J Surg 1987;153:177-83.
8. Vandenplas Y, Goyvaerts H, Helven R, Sacre L. Gastroesophageal reflux, as measured by 24-hour pH-monitoring in 509 healthy infants screened for risk of sudden infant death syndrome.Pediatrics 1991;88:834-40.
9. Schindlebeck NE, Heinrich C, Kownig A. Optimal thresholds, sensitivity and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology 1987;93:85-90.
10. Schwarz SM, Gerwitz MH, See CC, et al. Enteral nutrition in infants with congenital heart disease and growth failure.Pediatrics 1990;86:368-73.
11. Gorestky MJ, Johnson N, Farrell M, Ziegler MM. Alternative techniques of feeding gastrostomy in children: A critical analysis. J Am Coll Surg 1996;182:233-40.
12. Davidson PM, Catto-Smith AG, Beasley SW. Technique and complications of percutaneous endoscopic gastrostomy in children. Aust N Z J Surg 1995;65:194-6.
13. Marin OE, Glassman MS, Schoen BT, Caplan DB. Safety and efficacy of percutaneous endoscopic gastrostomy in children. Am J Gastroenterol 1994;89:357-60.
14. Larson DE, Burton DD, Schroeder KW, DiMagno EP. Percutaneous endoscopic gastrostomy. Indications, success, complication, and mortality in 314 consecutive patients. Gastroenterology 1987;93:48-52.
15. Cameron BH, Blair GK, Murphy JJ, Fraser GC. Morbidity in neurological impaired children after percutaneous endoscopic versus Stamm gastrostomy. Gastrointest Endosc 1995;42:41-4.
16. Heine HG, Reddihough DS, Catto-Smith AG. Gastro-esophageal reflux and feeding problems after gastrostomy in children with severe neurological impairment. Dev Med Child Neurol 1995;37:320-9.
17. Sondheimer JM, Morris BA. Gastroesophageal reflux among severely retarded children. J Pediatr 1979;94:710-4.
18. Gauderer MWL. Percutaneous endoscopic gastrostomy: A 10-year experience with 220 children. J Pediatr Surg 1991;26:288-94.
19. Grunow JE, Al-Hafidh A, Tunell WP. Gastroesophageal reflux following percutaneous endoscopic gastrostomy in children. J Pediatr Surg 1989;24:42-5.
20. Launay V, Gottrand F, Turk D, Michaud L, Ategbo S, Farriaux JP. Percutaneous endoscopic gastrostomy in children: Influence on gastroesophageal reflux. Pediatrics 1996;97:726-8.
21. Lewis D, Khoshoo V, Pencharz PB, Golladay ES. Impact of nutritional rehabilitation on gastroesophageal reflux in neurologically impaired children. J Pediatr Surg 1994;29:167-70.